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Background: Gliomas are the most common primary neoplasms of the 
central nervous system. Relative cerebral blood volume (rCBV) could 
estimate high-grade Gliomas computed with dynamic susceptibility contrast 
MR imaging which it is artificially lowered by contrast extravasation through 
a disrupted blood-brain barrier. 
Objectives: Our intent was to clarify the usefulness of diffusion-weighted 
magnetic resonance imaging (DWI) and perfusion weighted magnetic 
resonance imaging (PWI) in the grading of Gliomas.  
Materials and Methods: Both PWI and DWI with a three-tesla scanner 
investigated nineteen consecutive patients with Gliomas. The means of rCBV 
and ADC values have been compared among the tumor groups with t-test and 
ROC curve analysis to determine threshold values of Gliomas grading.  
Results: Mean maximum rCBV were 2.71±1.41 for low grades (I & II), and 
8.14±2.58 for high grades (III & IV) Gliomas (p=0.001). Mean minimum 
ADC were 1.47±.46 ×10
3
 mm
2
/s for low grades (I & II), and .47±.38×10
3
 
mm
2
/s for high grades (III & IV) Gliomas (p=0.001). We can get 0.94×10
3
 
mm
2
/s for minimum ADC and 3.85 for maximum rCBV as a difference cutoff 
point between low and high-grade Gliomas. 
Conclusion: Combination of both DWI and PWI techniques, with 
measurement of minimum ADC and maximum rCBV can be used to 
distinguish between high grade and low-grade Glioma tumors. 
 
 
 
 
 
 
 
Keywords: Diffusion Magnetic Resonance Imaging; Neoplasm Grading 
 
 
Article history: 
Received: 5 November 2015 
Accepted: 8 February 2016 
Available online: 6 March 2016 
CJNS 2016; 2 (4): 42-53 
 
 
1. Medical Imaging Physicist, Department of 
Radiology Technology, Faculty of Allied Medical 
Sciences, Shahid Beheshti University of Medical 
Sciences, Tehran, Iran 
 
2. Medical Physicist, Assistant Professor of Medical 
Imaging, Department of Radiology Technology, 
Faculty of Allied Medical Sciences, Shahid 
Beheshti University of Medical Sciences, Tehran, 
Iran 
 
3. Radiologist, Advanced diagnostic and 
Interventional Radiology Research Center 
(ADIR), Tehran University of Medical Sciences, 
Tehran, Iran 
 
4. Neurosurgen, Department of Neurosurgery, Emam 
Khomeini Hospital, Tehran University of Medical 
Sciences, Tehran, Iran 
 
5. Neuroscientist, Funding Member of  Iranian 
Society of Cellular and Molecular Imaging, 
Department of Anatomy and Neuroscience, 
Faculty of Medicine, Shahrekord University of 
Medical Sciences, Shahrekord, Iran 
 
6. Epidemiologist, Department of Epidemiology, 
Shahid Beheshti University of Medical Sciences, 
Tehran, Iran 
 
7. Radiologist, Emam Reza Hospital, Faculty of 
Medicine, Krmanshah University of Medical 
Sciences, Krmanshah, Iran 
 
 
*Corresponding author: 
Medical Physicist, Assistant Professor of 
Medical Imaging, Department of Radiology 
Technology, Faculty of Allied Medical 
Sciences, Shahid Beheshti University of 
Medical Sciences, Tehran, Iran 
Email: f_faeghi@sbmu.ac.ir 
 
  
Copyright © [2016] Caspian Journal of Neurological Sciences. All rights reserved. 
 
 Please cite this paper as: 
Saberi M, Faeghi F, Ghanaati H, Miri M, Rostamzadeh A, Khodakarim S, Naleini F.  
Grading of Glioma Tumors by Analysis of Minimum Apparent Diffusion Coefficient and 
Maximum Relative Cerebral Blood Volume. Caspian J Neurol Sci 2016; 2(4):42-53. 
  
 
Introduction  
liomas are the most common primary 
neoplasms of the central nervous 
system   and  are  classified  into  four  
 
 
grades by the World Health Organization 
(WHO) (1,2). Tumor grading has critical 
implications for preoperative planning G 
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therapeutic approaches, subsequent follow-up 
care, and assessing the patient prognosis and 
response to therapy (3). However, 
conventional magnetic resonance imaging 
(MRI) alone is not always accurate in predicting 
Glioma grade. Glioma grading is based on the 
histopathlogical assessment (3). Advanced 
MR imaging techniques such as DSC 
(Dynamic Susceptibility Contrast) and 
Diffusion Weighted Imaging (DWI) provide 
physiologic information that complements the 
anatomic information obtained from 
conventional MRI (3,4).  Diffusion is a term 
used to describe the movement of molecules 
due to random thermal motion restricted by 
boundaries such as ligaments, membranes and 
macromolecule. Sometimes restrictions in 
diffusion are directional, depending on the 
structure of the tissues. Diffusion of molecules 
also occurs across tissues, especially from 
areas of restricted diffusion to areas with free 
diffusion (3,5). The comprehensive 
displacement of molecules is called the 
apparent diffusion coefficient (ADC) and a 
sequence can be sensitized to this motion by 
applying two gradients on either side of the 
180
o
 radiofrequency (RF) pulse. This works in 
the similar way to phase contrast Magnetic 
Resonance Angiography (MRA) in that 
stationary spins will acquire no net phase 
change after applying the gradients. Moving 
spins, however, will acquire this phase change 
and result in a signal loss. In diffusion 
imaging, normal tissue has lower signal 
intensity than abnormal tissue, as the 
molecules within it are free to move, while 
diffusion becomes restricted when there is a 
pathologic change. The signal change depends 
on the ADC (Apparent Diffusion Coefficient) 
of the tissue and the strength of the gradients. 
Their amplitude are controlled by the b 
factor/value which is similar to the VENC 
(Encoding Velocity) in phase contrast MRA 
(4,5). This is another type of weighting in 
diffusion imaging; an extrinsic contrast 
parameter (b factor) controls how much a 
tissue's ADC contributes towards image 
weighting. If the TE (echo time) and TR 
(repetition time) are long and b=zero image is 
T2 weighted. If we then increase the b factor, 
then the image weighting changes from T2 to 
diffusion weighting. By this, we mean that 
areas will have a high signal not because they 
have a long T2 time but because they have a 
low ADC. This is why this technique is called 
diffusion weighted imaging. It is, in fact, 
another type of weighting. 'b' is expressed in 
units of s/mm
2 
(6). ADC maps are acquired via 
post-processing by calculating the ADC for 
each voxel of tissue and allocating signal 
intensity according to its value. Therefore, 
restricted tissue, which has a low ADC, is 
darker than free diffusing areas that have a 
high ADC (7). The contrast is therefore the 
mirror of the trace images. This is useful when 
T2 shine through is a problem. DWI quantifies 
cellularity based on the premise that water 
diffusion within the extracellular compartment 
is inversely related to the content and 
attenuation of the intracellular space (8). The 
higher the tumor cellularity and grade are lead 
to the lower the ADC and this fact is because 
of decreased water diffusion (4,9). However, 
other factors may be complicating this 
relationship: ADC increases with increased 
edema and increased edema is seen in high-
grade tumors. Differences in the restriction of 
water movement also can result from 
difference in tumor cellularity (7). Clinical 
perfusion measurements can be made with 
radiotracers, but as MRI is a non-ionizing 
technique with high spatial and temporal 
resolution that can be co-registered with 
anatomic information, there is much interest in 
perfusion MRI studies. Perfusion is the 
regional blood flow in tissues and is defined as  
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the volume of blood that flows into one gram 
of tissue. Perfusion is a measure of the quality 
of vascular supply to a tissue and, since 
vascular supply and metabolism are usually 
related, perfusion can be used to measure 
tissue activity (5,6). Perfusion is measured 
using MRI by tagging the water in arterial 
blood during image acquisition. Tagging can 
be achieved either by a bolus injection of 
exogenous contrast agent like gadolinium, or 
by saturating the protons in arterial blood with 
RF inversion or saturation pulses. As the 
difference between tagged and untagged 
images is so small, ultra-fast imaging methods 
are desirable for reducing artifact. In their 
simple forms, perfusion images can be 
acquired with fast-scanning acquisitions 
before, during and after a bolus injection of 
intravenous contrast (5,7,10). In one type of 
this technique uses a bolus injection of 
gadolinium is administered intravenously 
during ultra-fast T2 or T2
*
 acquisitions to 
evaluate perfusion. In this case, the contrast 
agent causes transient decreases in T2 and T2* 
decay in and around the microvasculature 
perfused with contrast. SS-GE-EPI (Single 
Shot-Gradient Echo-Echo Planar Imaging) 
sequences are usually used as they produce the 
required temporal resolution to measure such 
transient changes. In the brain, the first-pass 
extraction of contrast agent is zero when the 
blood–brain barrier (BBB) is reasonably 
intact, and the intravascular 
compartmentalization of contrast agent creates 
large, microscopic susceptibility gradients, 
and the dephasing of spins as they diffuse 
among them result in signal loss in T2 and T2
*
-
weighted images, as first described by 
Villringer (10). The microscopic susceptibility 
gradients caused by the contrast agent, cause 
signal loss in a manner that depends on the 
type   and   the   timing   of  the  applied  pulse  
 
sequence. Gradient echo EPI, especially when 
used with echo shifting (where the TE is 
longer than the TR) maximizes the 
susceptibility effects. After data acquisition, a 
signal decay curve is used to ascertain blood 
volume, transient time and measurement of 
perfusion (8,11). The measured MR signal 
intensity change versus time curve is 
converted into a contrast agent tissue 
concentration (ΔR2 or ΔR2*) versus time 
curve. This relationship is the key link 
allowing the calculation of cerebral 
hemodynamics. Tumor blood volume is 
calculated from the area under the T2 or T2
*
 
rate change (ΔR2 or ΔR2*) and ΔR2 (ΔR2*) 
can be calculated from signal intensity before 
and during the passage of contrast agent, as 
follows: 
 
ΔR2 (ΔR2*) = -ln  
𝑆 𝑡 
𝑆 0 
 /𝑇𝐸     Eq: 1 
Where S (t) is MR signal at time (t), S (0) is 
the mean MR signal before the arrival of 
contrast agent, and TE is echo time. Tumor 
blood volume can be normalized by volume of 
the reference tissue (e.g. white matter) to 
generate an index of tumor vascularity (11). It 
is generally assumed that T2 and T2* depend 
upon contrast agent concentration according to 
the following relationship:  
 
1
𝑇2∗(𝐶)
=
1
𝑇2∗(0)
+ 𝐶𝐵𝑉 𝑅∗𝐶
1
𝑇2(𝐶)
=
1
𝑇2(0)
+ 𝐶𝐵𝑉𝑅𝐶
      Eq: 2 
Where C is the concentration of the contrast 
agent in the blood, CBV is defined as the 
voxel volume occupied by blood vessels, and 
R or R* is the relaxivity of gadolinium-based 
contrast agent. Relaxivity depends on the 
molecular structure and kinetic of the 
complex, second sphere water exchange, and 
the rotational dynamics of the molecule. The 
T2 and T2* effects of a contrast agent are 
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almost entirely determined by its magnetic 
susceptibility, i.e. its tendency to enhance 
magnetic fields, so the molecular chemistry of 
the agent is important only to the extern that it 
affects susceptibility. Unfortunately, the 
relaxation of the agent is not certain (11,12). A 
theory for the 12 effects of contrast in vessels 
could help us to estimate R*. According to it 
that R* is not strongly dependent on tissue 
type as long as the blood volume is 
predominantly large enough in vessels, usually 
larger than capillaries, that diffusion is not 
important, and they are randomly oriented. 
However, been a report demonstrating that R 
is significantly smaller in tissues with complex 
microvascular structure, such as kidney and 
spleen than in other tissues (12). Time 
intensity curves for multiple images acquired 
during and after injection are combined to 
generate a cerebral blood volume (CBV) map. 
CBV is measured in unit of ml/100g/min and 
can be calculated by the integration of the 
concentration versus time curve. CBV reflects 
any increase in the cerebral capillary and 
venular beds, such as vasodilation or in 
angiogenesis (7). The angiogenic process is 
complex and can be stimulated by any one of 
several mechanisms. Typically, growth of 
tissue, which has outstripped its local blood 
supply, results in regional hypoxia and 
hypoglycemia that stimulates the release of 
local chemical messengers from the cells of 
the tissue itself. The best known of these 
messengers is the cytokine, vascular 
endothelial growth factor (VEGF). VEGF is a 
common and potent angiogenic stimulator that 
is found in many pathological tissues. It is 
released in response to local hypoglycemia 
and/or hypoxia and has several effects, each of 
which will improve metabolic supply. In the 
short term, VEGF will act directly on local 
capillaries to increase endothelial permeability 
resulting in an immediate increase in the 
supply of nutrients (13). This increase in 
permeability is also believed to form an 
important part of the metastatic mechanism, 
allowing passage of tumor cells into the 
circulation (14). DSC provides noninvasive 
assessment of tumor vascularity and 
angiogenesis (4,8,15) through the examination 
of the degradation of signal intensity with time 
associated with the first pass of a bolus of 
paramagnetic contrast agent (16). Because 
higher vascularity corresponds to a higher 
tumor grade, as the grade of the astrocytoma 
increases, the maximum tumor CBV tends to 
increase (8,15). Recent developments in MRI 
have allowed for the assessment of cerebral 
blood volume (CBV) derived from perfusion-
weighted MRI and perfusion abnormalities in 
brain tumors. An important factor in the 
malignancy of tumors is their ability to recruit 
and synthesize vascular networks for further 
growth and proliferation. Relative cerebral 
blood volume (rCBV) maps and 
measurements have been shown to correlate 
reliably with tumor grade and histological 
findings of increased tumor vascularity 
(17,18): 
 
rCBV =  
 Volume  of  blood  in  a voxel
Mass  of  the  voxel
         Eq: 3 
The aim of this study was to evaluate the 
diagnostic accuracy of combined ADC and 
CBV values in the preoperative differentiation 
of diffuse Gliomas. Our objectives were as 
follow. 1) To calculate CBV and ADC values 
for diffuse Gliomas included in the study. 2) 
To establish whether there is any difference in 
rCBV and ADC values in Gliomas classified 
by tumor grade and histology. 3) To estimate a 
cut-off CBV and ADC value for 
differentiation of high- and low-grade 
Gliomas. 4) To investigate whether combined 
CBV and ADC values improve the diagnostic 
accuracy of MRI. 
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Materials and Methods 
Patient Population 
We retrospectively reviewed data obtained 
during a 1-year period (September 2013 - 
September 2014) from 19 patients with a 
histopathologically proved diagnosis of 
Glioma. They underwent an MR imaging 
study at our hospital (Imam Khomeini 
Hospital, Tehran, Iran) after signing a written 
informed consent.  
 Diagnosis was histologically confirmed by 
surgical resection or biopsy. The tumor 
specimens obtained were examined by 
neuropathologist and graded as low-grade 
(grades I and II) and high grade (grades III and 
IV) tumors according to the WHO 
Classification of Tumors of the Central 
Nervous System (2007) (19). 
 
Conventional MRI 
Imaging was performed with a three-tesla 
scanner (MAGNETOM TRIO A Tim 
SIEMENSE). We performed the following 
anatomic sequences: a 3-plane localizer 
sequence, T2_tirm_tra_dark-fluid_5mm 
(TR_8910 ms, TE_93 ms, TI_2489 ms), T2 
_tse_tra_384_5mm (TR_3230 ms, TE_93 ms), 
T2_tse_sag_320_ 4mm (TR_4410, TE_77), 
T2_tse_cro_320_4mm (TR_5510 ms, TE_77), 
and t1_fl2d_tra (TR_401 ms, TE_2.48 ms). 
All data were obtained by using 5mm thick 
sections with distance factor 20%, FOV 
read_220mm and FOV phase_75%. 
PWI Parameters 
Dynamic contrast–enhanced T2*-weighted 
gradient-echo echo-planar images were 
acquired  during  the  first  pass  of  a  bolus of 
Dotarem, 1 mmol/mL at a dose of 0.1 
mmol/kg. Nineteen sections were selected for 
perfusion MR imaging to cover the tumor 
based on T2-weighted and FLAIR images. For 
the sixth acquisition, Dotarem was injected at 
a rate of 4 mL/s with a power injector 
followed by administration of a 20-mL bolus 
of saline at 4 mL/s.  
DWI parameters 
DWI was performed before administration 
of contrast medium by using a multi-shot spin-
echo echo-planar imaging sequence with the 
following parameters: TR/TE_3500/93 ms, 
image acquisition in the axial plane, slice 
thickness 4-mm, distance factor 30%, number 
of slice_21, FOV read 220mm , FOV phase 
100mm , b-values of 0 and 1000 s/mm
2
. 
Perfusion MRI Data Evaluation 
DSC images were processed by using 
commercially available Perfusion Map 
Analysis (PMA) software. The beginning and 
the end of the first-pass bolus were determined 
through inspection of the time–signal-intensity 
curve and care was taken to exclude any 
recirculation-related signal intensity. Cerebral 
blood volume refers to the amount of blood in 
a given region of brain tissue at any time, 
commonly measured in milliliters per 100 g of 
brain tissue. Because the CBV must be 
expressed relative to an internal reference, we 
normalized it by expressing ratios relative to 
values measured in the normal white matter of 
the contralateral lobe. We have referred to 
these relative values as rCBV. If we want to 
gain rCBV map, Arterial Input Function (AIF) 
should not be determined for bolus of contrast. 
Color-coded rCBV maps were generated to 
target regions of maximum abnormality. We 
placed 3 ROIs (Region of Interest) within the 
tumor, on areas showing the highest intra-
tumoral rCBV on the maps. The standardized 
ROI was 2–3mm2, which was used for most of 
the tumor and white matter measurements 
(Figure 1). Care was taken not to include large 
intra- or peri-tumoral vessels because these 
can confound perfusion measurements. The 
maximum rCBV value in intratumoral ROIs 
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was selected for quantitative analysis and 
correlated with corresponding specimen histo-
pathology. This method has been 
demonstrated to provide the most optimal inter 
observer and intra observer reproducibility 
(20). 
 
Diffusion MRI Data Evaluation 
ADC maps and values were calculated by 
using commercially available PMA software  
with the ROIs. This software has been 
designed for analysis both DWI and PWI 
images and we can calculate ADC with draw 
ROIs in ADC map on interested area of tumor. 
Five circular ROIs (areas ranging from 1 to 2 
mm
2
) were manually constructed and placed 
over the whole tumor to select the region of 
the maximum hypo intensity corresponding to 
the solid portion of tumor. Afterward, the 
minimum ADC obtained was selected for the 
analysis. The ROIs were carefully placed to 
avoid cystic, necrotic, and hemorrhagic 
regions that might influence ADC values 
(Figure 1). 
 
 
 
 
 
 
 
 
 
Statistical Analysis 
An access database was created to track 
maximum rCBV, minimum ADC, and tumor 
grade of diffuse Gliomas. Using the Statistical 
Package for the Social Sciences Version 16 
software (SPSS), we performed statistical 
analysis. At first, we check the normality of 
our data with Kolmogorov–Smirnov Z test. 
With these test we found that both group 
values (ADC & rCBV) have normality 
distribution; so mean rCBV and ADC values 
were compared among the tumor groups with 
the Standard t test. A p<0.001 indicated a 
statistically significant difference. A ROC 
curve analysis was obtained to determine the 
cutoff point of rCBV and ADC values that 
had the best combination of specificity and 
sensitivity for differentiating high and low-
grade Gliomas. In the ROC curve, the size of 
the area under the curve indicated the degree 
of the relationship between rCBV or ADC 
values and the grade of the Gliomas: the 
closer to one, have stronger relationship. 
Results 
 
Patient Population 
The group consisted of 19 patients (8 men 
and 11 women), with ages ranging from 11 to 
62 years. We investigated 9 low-grade  
(47.37%) and 10 high-grade Gliomas 
(52.63%). 
 
Evaluation of rCBVmax & ADCmin Values 
for Glioma Grading 
rCBV values were significantly effective 
in grading glial tumors as low-grade and 
high-grade    (p=0.0009).    Although      some  
 
Figure 1: Images of T2 (a), ADC (b) , PWI (c) and rCBV map (d) in a 47 year-old  man with a right temporal grade II astrocytoma. We placed 3 ROIs 
within the tumor, on areas showing the highest intra-tumoral rCBV on the map, and we calculated ADC with draw five ROIs in ADC map, on 
interested area of tumor. 
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overlap of distribution was shown between 
the values of the two groups, rCBV values 
were statistically different between grade II 
and grade IV Gliomas. ADC measurements 
were significantly effective in grading glial  
 
 
tumors as low-grade and high-grade 
(p=0.0004). As we found in Diffusion data 
analysis, some overlap of distribution was 
shown between the ADC values of two 
groups. (Table1)  
 
Table 1: The means of rCBV* and ADC** in high-grade and low-grade Gliomas 
 Group  N     Range of data  Mean±SD*** Std. Error 
Mean 
p-value 
rCBV High  10    4.30-13.40 8.14±2.58 .81 0.0009 
Low  9        0.9-4.32 2.71±1.41 .47  
ADC High 10        0.17-1.46 .47±.38 .12 0.0004 
Low 9         0.63-2.10 1.47±.46 .15  
* relative Cerebral Blood Volume  
**Apparent Diffusion Coefficient (×103 mm2/s)    
*** Standard Deviation 
 
According to the ROC curves, the rCBV 
cutoff value of 3.85 showed high sensitivity 
(100%) in the characterization of high-grade 
Gliomas. The ADCmin cutoff value of 
0.94×10
3 
mm
2
/s generated the best 
combination of sensitivity (88.9%) and 
specificity (90%) in the discrimination of 
high- and low-grade Gliomas. In that setting, 
the area under the ROC curve was 0.978 and 
0.933 for the maximum rCBV and minimum 
ADC, respectively. (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: ROC curve analysis showing the effect of using ADC min (A) and rCBV max (B) as individual in differentiating high- and 
low-grade Gliomas. The area under the ROC curve for minimum ADC= 0.933, and the maximum rCBV= 0.978 respectively. 
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An inverse correlation has been found 
between ADC and rCBV with changing the 
grade of tumor (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
Accurate grading of Gliomas is of 
importance because the therapeutic approach 
and prognosis differ considerably according 
to tumor grade (21,22). Whereas conventional 
MR imaging provides information on contrast 
enhancement, mass effect, edema, and 
necrosis, it is not always accurate for the 
precise grading of Gliomas (21). Advanced 
MR imaging techniques such as perfusion and 
diffusion MR imaging have demonstrated 
utility for the assessment of brain tumors 
(21). Thus, MR imaging perfusion methods 
allow the creation of CBV maps that are 
potentially useful in the characterization of 
Gliomas, because tumor aggressiveness and 
growth are associated with endothelial neo-
vascularization. Although previous studies 
have suggested that contrast enhancement 
alone is not sufficient to predict tumor grade 
(23), because some low-grade Gliomas 
demonstrate contrast enhancement while 
some high-grade tumors do not (22,24). The  
 
extent of contrast enhancement has been 
traditionally used as a marker of malignancy 
(4,22). The rCBV measurements correlate 
with the tumor grade and the histologic 
findings of increased vascularity of the tumor 
(21,25,26). Previous studies published 
between 1999 and 2005 found a range of 
rCBV values from 1.11 to 1.69 in low-grade 
Gliomas and from 3.64 to 7.32 in high-grade 
Gliomas, respectively. These values are 
comparable with our findings in our series of 
19 patients, with mean rCBV values of 8.13 
and 2.70 for high-grade and low-grade 
Gliomas, respectively. Several studies have 
found statistically significant discrimination 
between high-grade and low-grade Gliomas 
(21,27-29). Our findings are in agreement 
with these results, demonstrating significant 
differences in the rCBV values between high 
and low grade tumors. We have also found 
that rCBV values were statistically different 
between grade II and IV Gliomas. Even more, 
our results support histologic findings that 
most grade II Gliomas differ from grade IV 
tumors by the presence of microvascular 
proliferation. Similar series by Lev et al. (30) 
and Hakyemez et al. (3) found a sensitivity of 
100% in discriminating the high- and low-
grade tumors with the use of 1.5 and 2 as the 
rCBV threshold value, respectively. A series 
published in 2005 by Calli C, et al. found the 
rCBV threshold value of 1.75 with a 
sensitivity of 95% and specificity of 57.5% 
(31). In our study of 19 Gliomas, we found 
similar results to those of Law et al. 
(sensitivity, 94.4%; specificity, 50%) using a 
cutoff value of 1.74 (14). Our results are also 
in agreement with those published by Lev et 
al. (32) and show us that as the threshold 
level is lowered, the specificity is decreased 
and some low-grade Gliomas are falsely 
identified  as  high-grade  and  will be treated  
Figure 3: Inverse correlation between ADC and rCBV with 
changing the grade of glioma. RSq Linear=0.595 
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more aggressively. In our group of patients, 
on the other hand, sensitivity decreased to 
91.2% when the rCBV cutoff value was 
increased to 3.29. These results are in 
agreement with those published by Shin et al. 
who reported 91% sensitivity and 83% 
specificity for a cutoff value of 2.9 in a group 
of 19 Gliomas (33). With these cutoff values, 
some high-grade Gliomas would be 
misidentified as low-grade tumors and would 
be treated conservatively, resulting in a 
potentially rapid death. Some authors 
suggested that quantitative perfusion imaging 
predicts tumor biologic activity and survival 
better than histopathologic grade does. We 
are in agreement with the above argument 
that DSC can be used to predict clinical 
outcome in patients with low-grade Gliomas, 
independent of pathologic findings. DWI 
allows assessing the cellularity of tumors in a 
noninvasive form; because cellular and 
subcellular elements impede water mobility 
(34) and quantitative information from the 
restriction of water molecule movement can 
be observed in calculating the ADC (35,36), 
Thus, brain neoplasms with higher cellularity 
or with a higher grade show a significant 
reduction in ADC values (36,37). In our 
series of 19 Gliomas, we found a significant 
difference in the minimum ADC value for 
differentiating the low and high-grade 
Gliomas. These findings are similar to those 
reported previously by Lee et al. (n=16) (22), 
Kono et al. (n=17) (35), and Calli et al. 
(n=31) (31), with high-grade Gliomas 
showing a significant reduction in ADC 
values and increased signal intensity on DWI. 
Our findings also agree with those 
demonstrated by Yamasaki et al.; this 
similarity suggests an inverse relationship 
between ADC and glial tumors of WHO 
grades II–IV (38).   Most   of   the   published  
 
studies to date have evaluated the diffusion 
properties in high- and low-grade Gliomas. 
We have gone one-step further and have 
studied the ADC values in the Gliomas 
classified by grade and histology. According 
to this, ADC measurements are better than 
rCBV values in distinguishing the grades of 
Gliomas and astrocytic tumors. In our 
experience, the mean ADC value was 
0.475×10
3 
mm
2
/s for high grade Gliomas and 
lower than ADC values published by Stadnik 
et al. who reported the mean ADC values of 
1.14×103 mm2/s (39). The reason for our 
lower ADC values may be that we always 
sampled the minimum ADC value from the 
solid portion of the tumor. The cutoff value of 
0.94×10
3
 mm
2
/s for the minimum ADC 
generated the best combination of sensitivity 
(88.9%) and specificity (90%) in the 
discrimination of high- and low grade 
Gliomas. In the present study, we were 
interested in determining whether combined 
data from rCBV and ADC values could 
improve the diagnostic accuracy of perfusion 
and diffusion alone. An inverse correlation 
has been found between ADC and rCBV with 
changing the grade of tumor. This comes back 
to histopathological characteristics of cell 
tumors. With increase the grade of tumor, we 
can see a large increase in number of cells. 
Therefore, it causes a decrease in the extra 
space between cells, so restriction in water 
molecules motion and decease in ADC 
values. In the other hand, we can see an 
increase in the vascularization of tumor tissue 
and total volume of blood in them. Therefor 
we can see this inverse correlation. 
This was the work that the combination of 
diffusion and perfusion MR imaging has been 
used as a diagnostic tool in the presurgical 
evaluation of Gliomas. Our results show that 
the   area    under  the   ROC   curve   for   the  
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maximum rCBV was 0.978 and 0.933 for the 
minimum ADC. According to these results, 
the classification accuracy based on 
maximum rCBV was higher than that based 
on minimum ADC, we may conclude that the 
combination of ADC and rCBV values 
increases the diagnostic accuracy of MR 
imaging in the preoperative grading of 
Gliomas. Kim et al. also found an adjunctive 
value of perfusion MR imaging (pulsed 
arterial spin-labeling) and ADC scoring in the 
Glioma grading compared with conventional 
images alone (26). However, there have been 
few reports of the simultaneous use of 
perfusion and diffusion imaging in Glioma 
grading, and further studies will be needed. 
There are some limitations in our study. First, 
stereotactic biopsies were not targeted by 
rCBV or ADC maps. Second, there is the 
possibility of histopathologic misdiagnosis 
attributable to sampling error in the 
pathologic examination because of the 
histologic heterogeneity of tumor tissues. It is 
widely known that a given individual Glioma, 
usually of high grade, often contains a 
continuum of histologic features of grades II-
IV and tumor grading is dependent on the site 
of tumor biopsy or resection and thus subject 
to sampling error or under sampling.  
 
Conclusion  
Our results showed that ADC and rCBV 
maps could be used as a noninvasive method 
of evaluation of tumor grade. We have found 
that rCBV measurements are better than ADC 
values in distinguishing the grades of Glioma. 
Although further studies will be needed to 
confirm the utility of combined diffusion 
weighted and perfusion MR imaging, the 
results also suggested that the combination of 
minimum    ADC    and    maximum     rCBV  
 
improves the diagnostic accuracy of MR 
imaging in the preoperative determination of 
Glioma grade. 
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